Literature DB >> 33266042

The Role of APOBECs in Viral Replication.

Wendy Kaichun Xu1,2, Hyewon Byun1, Jaquelin P Dudley1,3.   

Abstract

Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) proteins are a diverse and evolutionarily conserved family of cytidine deaminases that provide a variety of functions from tissue-specific gene expression and immunoglobulin diversity to control of viruses and retrotransposons. APOBEC family expansion has been documented among mammalian species, suggesting a powerful selection for their activity. Enzymes with a duplicated zinc-binding domain often have catalytically active and inactive domains, yet both have antiviral function. Although APOBEC antiviral function was discovered through hypermutation of HIV-1 genomes lacking an active Vif protein, much evidence indicates that APOBECs also inhibit virus replication through mechanisms other than mutagenesis. Multiple steps of the viral replication cycle may be affected, although nucleic acid replication is a primary target. Packaging of APOBECs into virions was first noted with HIV-1, yet is not a prerequisite for viral inhibition. APOBEC antagonism may occur in viral producer and recipient cells. Signatures of APOBEC activity include G-to-A and C-to-T mutations in a particular sequence context. The importance of APOBEC activity for viral inhibition is reflected in the identification of numerous viral factors, including HIV-1 Vif, which are dedicated to antagonism of these deaminases. Such viral antagonists often are only partially successful, leading to APOBEC selection for viral variants that enhance replication or avoid immune elimination.

Entities:  

Keywords:  AID; APOBEC; DNA virus replication; G-to-A mutations; HIV-1 Vif; MMTV Rem; RNA virus replication; genome hypermutation; viral variants

Year:  2020        PMID: 33266042      PMCID: PMC7760323          DOI: 10.3390/microorganisms8121899

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  379 in total

1.  APOBEC-mediated editing of viral RNA.

Authors:  Kate N Bishop; Rebecca K Holmes; Ann M Sheehy; Michael H Malim
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

2.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

3.  Plastic restriction of HIV-1 replication in human macrophages derived from M1/M2 polarized monocytes.

Authors:  Francesca Graziano; Elisa Vicenzi; Guido Poli
Journal:  J Leukoc Biol       Date:  2016-06-30       Impact factor: 4.962

4.  RNA-Mediated Dimerization of the Human Deoxycytidine Deaminase APOBEC3H Influences Enzyme Activity and Interaction with Nucleic Acids.

Authors:  Yuqing Feng; Lai Wong; Michael Morse; Ioulia Rouzina; Mark C Williams; Linda Chelico
Journal:  J Mol Biol       Date:  2018-11-09       Impact factor: 5.469

5.  Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice.

Authors:  Kei Sato; Taisuke Izumi; Naoko Misawa; Tomoko Kobayashi; Yoshiki Yamashita; Masahide Ohmichi; Mamoru Ito; Akifumi Takaori-Kondo; Yoshio Koyanagi
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.

Authors:  James A Dutko; Alexandra Schäfer; Alison E Kenny; Bryan R Cullen; M Joan Curcio
Journal:  Curr Biol       Date:  2005-04-12       Impact factor: 10.834

7.  APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia.

Authors:  Xia Jin; Andy Brooks; Huiyuan Chen; Ryan Bennett; Richard Reichman; Harold Smith
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection.

Authors:  Kalani Halemano; Kejun Guo; Karl J Heilman; Bradley S Barrett; Diana S Smith; Kim J Hasenkrug; Mario L Santiago
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

9.  Molecular cloning of an apolipoprotein B messenger RNA editing protein.

Authors:  B Teng; C F Burant; N O Davidson
Journal:  Science       Date:  1993-06-18       Impact factor: 47.728

10.  Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons.

Authors:  Viviana Cobos Jiménez; Thijs Booiman; Steven W de Taeye; Karel A van Dort; Maarten A N Rits; Jörg Hamann; Neeltje A Kootstra
Journal:  Sci Rep       Date:  2012-10-23       Impact factor: 4.379

View more
  14 in total

1.  Divergence in Dimerization and Activity of Primate APOBEC3C.

Authors:  Amit Gaba; Mark A Hix; Sana Suhail; Ben Flath; Brock Boysan; Danielle R Williams; Tomas Pelletier; Michael Emerman; Faruck Morcos; G Andrés Cisneros; Linda Chelico
Journal:  J Mol Biol       Date:  2021-10-16       Impact factor: 6.151

2.  Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.

Authors:  Jeremy Ratcliff; Peter Simmonds
Journal:  Virology       Date:  2021-01-07       Impact factor: 3.616

Review 3.  Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein.

Authors:  Benjamin Stupfler; Cédric Verriez; Sarah Gallois-Montbrun; Roland Marquet; Jean-Christophe Paillart
Journal:  Viruses       Date:  2021-04-03       Impact factor: 5.048

4.  Encapsidation of Staufen-2 Enhances Infectivity of HIV-1.

Authors:  Kannan Balakrishnan; Ananda Ayyappan Jaguva Vasudevan; Krishnaveni Mohareer; Tom Luedde; Carsten Münk; Sharmistha Banerjee
Journal:  Viruses       Date:  2021-12-08       Impact factor: 5.048

5.  AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19.

Authors:  Anastasia Meshcheryakova; Peter Pietschmann; Philip Zimmermann; Igor B Rogozin; Diana Mechtcheriakova
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

Review 6.  Foamy Viruses, Bet, and APOBEC3 Restriction.

Authors:  Ananda Ayyappan Jaguva Vasudevan; Daniel Becker; Tom Luedde; Holger Gohlke; Carsten Münk
Journal:  Viruses       Date:  2021-03-18       Impact factor: 5.048

Review 7.  Human APOBEC3 Variations and Viral Infection.

Authors:  Shiva Sadeghpour; Saeideh Khodaee; Mostafa Rahnama; Hamzeh Rahimi; Diako Ebrahimi
Journal:  Viruses       Date:  2021-07-14       Impact factor: 5.818

8.  Inhibition of base editors with anti-deaminases derived from viruses.

Authors:  Zhiquan Liu; Siyu Chen; Liangxue Lai; Zhanjun Li
Journal:  Nat Commun       Date:  2022-02-01       Impact factor: 14.919

9.  Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.

Authors:  Amir Farmanbar; Sanaz Firouzi; Robert Kneller; Hossein Khiabanian
Journal:  J Transl Med       Date:  2022-02-02       Impact factor: 5.531

Review 10.  Insights into the Structures and Multimeric Status of APOBEC Proteins Involved in Viral Restriction and Other Cellular Functions.

Authors:  Xiaojiang S Chen
Journal:  Viruses       Date:  2021-03-17       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.